MedUni Vienna researchers discover possible trigger of chronic inflammatory bowel disease

As the cause of chronic inflammatory bowel diseases (IBD) such as Crohn’s disease or ulcerative colitis is not yet known, treatment for sufferers is currently aimed at alleviating the often agonizing symptoms.

Introducing Chemspeed’s new corporate design

We are thrilled to announce the launch of Chemspeed’s new Corporate Design! This update marks a significant milestone in our journey to modernize and strengthen

August 27, 2024

CRISPR-based assay could revolutionise diagnosis of NTM infections – Pharmaceutical Technology

Share this article NTM are opportunistic pathogens that are responsible for causing infections in patients with pre-existing health conditions or compromised immune systems. Image: Kateryna

March 25, 2024

Hair Growth After Cancer; ‘Global’ Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

Oral minoxidil promoted hair regrowth with no serious side effects in women who had hair loss related to breast cancer treatment. (NYU Langone Health, Journal

December 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.